Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award

Forecast Expected deadline February 16, 2027 Opportunity PAR-28-008

National Institutes of Health plans to offer grants to the applicants described in the notice. It is a forecast: the notice is expected around September 1, 2026, with applications due around February 16, 2027.

From the official notice on Grants.gov, last changed July 20, 2026. Checked October 31, 2026.

Key dates

Forecast postedJuly 20, 2026
Expected postingSeptember 1, 2026
Expected deadlineFebruary 16, 2027
Expected award dateDecember 15, 2027

Add the deadline to your calendar

Who can apply

This opportunity is open to the applicants described in the notice.

Eligibility for this NOFO is limited to recipients that have successfully competed for an award under the Clinical and Translational Science Awards (CTSA) UM1 NOFO PAR-24-272 or subsequent iterations, as either a prime recipient or as a partnering institution.

Is this a realistic fit?

What the grant funds

The purpose of the Congressionally mandated Clinical and Translational Science Award (CTSA) Program is to accelerate the translation of scientific discoveries into treatments, diagnostics, and health interventions that improve patient and public health by funding and coordinating a national network of academic medical centers that provide the infrastructure, expertise, training, and collaboration needed to move discoveries from the laboratory into clinical practice and community health. The purpose of the reissuance of the Collaborative and Innovative Acceleration Award for the CTSA Program Notice of Funding Opportunity (NOFO) is to support the collaborative development of innovative approaches, technologies, or models that synergistically enhance the impact of research, advance translational science, and bring more treatments for all people more quickly. Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. This is a Forecast for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

Category: Health.

How to apply

  1. Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
  2. Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
  3. Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.

Questions go to Division of Clinical Innovation, NCATS, ctsa_collaborativeinnovation@mail.nih.gov, Please contact via e-mail..

Open the official notice

Questions people ask

Who can apply for Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award?

National Institutes of Health accepts applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

What is the deadline for Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award?

Expected deadline February 16, 2027. Confirm the date and time in the official notice on Grants.gov.

Similar open grants